Trial
NCT01741753
BKM120+Abiraterone Acetate for Metastatic CRPC
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
—
Condition
Prostate Cancer
Intervention
BKM120
Why stopped
Due to slow accrual the supllier of BKM120 asked we cease further enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-05